On a molecular level, pathways involving TGF-β signaling, endothelial injury, and extracellular matrix remodeling have been repeatedly described in CPFE, overlapping but not identical to those in IPF or COPD [21]. The gene discussed is TGFB1; the disease is chronic obstructive pulmonary disease.